Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06292026 · ClinicalTrials.gov registry record · NA
Efficacy of ProgenaMatrix™ in the Management of DFUs
A NA study of Diabetic Foot Ulcer, sponsored by ProgenaCare Global.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06292026 is a NA study of Diabetic Foot Ulcer that is active but no longer recruiting, run by ProgenaCare Global. The registered enrollment target is 100 participants, below the 253-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06292026, a NA study of Diabetic Foot Ulcer, is active but no longer recruiting, sponsored by ProgenaCare Global.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This multicenter study will collect data to determine closure time for diabetic ulcers when following protocol parameters and treatment with ProgenaMatrix™.
Conditions Studied
Interventions
- DEVICE ProgenaMatrix Keratin graft
- OTHER standard of care
Study Locations (1)
Washington
- United Wound Healing - Puyallup
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-03-14 |
| Est. Completion | 2026-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06292026
The ClinicalTrials.gov registry entry for NCT06292026 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 253-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (60% lower). The listed sponsor is ProgenaCare Global, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 2 interventions - of which ProgenaMatrix Keratin graft is the first listed.
NCT06292026 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT06292026 about?
NCT06292026 is a clinical study titled "Efficacy of ProgenaMatrix™ in the Management of DFUs". This multicenter study will collect data to determine closure time for diabetic ulcers when following protocol parameters and treatment with ProgenaMatrix™.
What is the current status of trial NCT06292026?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-03-14. Estimated completion is 2026-09.
What conditions does trial NCT06292026 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer.
What interventions are being tested in trial NCT06292026?
The interventions under investigation include: ProgenaMatrix Keratin graft (DEVICE), standard of care (OTHER).
Who is sponsoring clinical trial NCT06292026?
This trial is sponsored by ProgenaCare Global, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06292026 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
RECRUITING · NA
-
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.